Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
出版年份 2021 全文链接
标题
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
作者
关键词
-
出版物
Cancer Communications
Volume 42, Issue 1, Pages 3-16
出版商
Wiley
发表日期
2021-10-27
DOI
10.1002/cac2.12225
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Paradigms on Immunotherapy Combinations with Chemotherapy
- (2021) Diego Salas-Benito et al. Cancer Discovery
- Chemokines and the immune response to cancer
- (2021) Aleksandra J. Ozga et al. IMMUNITY
- Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
- (2020) Robert Jotte et al. Journal of Thoracic Oncology
- IL-8 and cancer prognosis on immunotherapy
- (2020) Ziad Bakouny et al. NATURE MEDICINE
- Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
- (2020) Kurt A. Schalper et al. NATURE MEDICINE
- High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
- (2020) Kobe C. Yuen et al. NATURE MEDICINE
- Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy
- (2020) Shoujian Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)
- (2019) Zhen Wang et al. EUROPEAN JOURNAL OF CANCER
- Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer
- (2019) Rafał Suwinski et al. BMC CANCER
- Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma
- (2018) Guofu Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer
- (2018) Yijun Jia et al. LUNG CANCER
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR -Mutated Non–Small Cell Lung Cancer
- (2017) Emily Castellanos et al. Journal of Thoracic Oncology
- Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
- (2016) L. Paz-Ares et al. ANNALS OF ONCOLOGY
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
- (2015) Chee-Seng Tan et al. LANCET ONCOLOGY
- Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry
- (2014) Jiandong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical Comparison between Paclitaxel Liposome (Lipusu®) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer
- (2013) Xu Xu et al. Asian Pacific Journal of Cancer Prevention
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Modulation of peripheral immune responses by paclitaxel–ifosfamide–cisplatin chemotherapy in advanced non-small-cell lung cancer
- (2013) Nikolaos Koufos et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
- (2010) Danny R. Youlden et al. Journal of Thoracic Oncology
- A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
- (2008) Qian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started